| Home |
| News |
| Newsletters |
| The Project |
| About |
| Board |
| Bylaws |
| Membership |
| Members |
| Disclaimer |
| Sponsorship |
| Sponsors |
| Contact info |
The European Myeloma Network
(EMN)
The European Myeloma Network was established in 2003 by integrating 27 research institutions and 14 trial groups with the intent to support development of novel diagnostics and therapies for multiple myeloma. Now, EMN is legalised and ready to initiate and support co-operative clinical trials and laboratory research.
The Myeloma Stem Cell Network (MSCNET)
is part of EMN. It is supported by
EU's Sixth Framework Programme.
News
| The 2nd European Multiple Myeloma Workshop | ||
|
||
| 14 May 2008 by EMN | ||
| Please support the Europen Myeloma Network by nominating our Chairman Pieter Sonneveld before April 4th 2008 | ||
|
||
| 1 Apr 2008 by EMN | ||
| FP7: "Health Programme Committee" | ||
|
||
| 5 Jul 2007 by EMN | ||
| Read the EMN posters and slides presented at the KOS meeting 2007 | ||
|
||
| 2 Jul 2007 by EMN | ||
| EMN report from the chairman (Vienna 2007) | ||
|
||
| 14 Jun 2007 by EMN | ||
| Register your free EMN membership - Now more than 122 registered members | ||
|
||
| 22 May 2007 by EMN | ||
| 12th EHA Congress in Vienna - Scientific Working Group Meeting | ||
|
||
| 1 May 2007 by EMN | ||
Workpackages
WP1: Homepage
WP2: Clinical data registration
WP3: Tissue banks
WP4: Clinical network
WP7: Proliferation and apaptosis
WP8: Immune system and micro enviroment
WP9: Animal models and cell lines
WP10: Tumor clone characteristics
WP11: Host-tumor interactions
WP12: Minimal residual disease
WP13: Clinical validation
WP14: New drug development
